These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6909029)

  • 41. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
    Alessio L; Bertazzi PA; Cortona G
    Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
    [No Abstract]   [Full Text] [Related]  

  • 42. Reassessment of the threshold of the blood lead level to increase urinary δ-aminolevulinic acid based on their relationship in recent lead workers in Japan.
    Ono A; Horiguchi H
    J Occup Health; 2021 Jan; 63(1):e12202. PubMed ID: 33543569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary 5-aminolevulinic acid (ALA) adjusted by creatinine: a surrogate for plasma ALA?
    Sithisarankul P; Schwartz BS; Lee BK; Strickland PT
    J Occup Environ Med; 1998 Oct; 40(10):901-6. PubMed ID: 9800176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sex difference in free erythrocyte protoporphyrin (FEP) level. II. Sex difference in FEP level in rats exposed to lead].
    Ohmori S; Harada K; Miura H
    Sangyo Igaku; 1992 Jul; 34(4):349-54. PubMed ID: 1518191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behaviour of indicators of exposure and effect after cessation of occupational exposure to lead.
    Alessio L; Castoldi MR; Odone P; Franchini I
    Br J Ind Med; 1981 Aug; 38(3):262-7. PubMed ID: 7272239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benchmark dose approach for low-level lead induced haematogenesis inhibition and associations of childhood intelligences with ALAD activity and ALA levels.
    Wang Q; Ye LX; Zhao HH; Chen JW; Zhou YK
    Sci Total Environ; 2011 Apr; 409(10):1806-10. PubMed ID: 21334730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of erythrocyte delta-aminolevulinic acid dehydrase and its change by heat treatment as indices of lead exposure.
    Chiba M
    Br J Ind Med; 1976 Feb; 33(1):36-42. PubMed ID: 1268106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects.
    Morita Y; Araki S; Sakai T; Araki T; Masuyama Y
    Ind Health; 1994; 32(2):85-96. PubMed ID: 7806449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biochemical and electrophysiological studies in subjects with occupational exposure to lead poisoning].
    Kazibutowska Z; Mierzwa P; Mierzwa E
    Neurol Neurochir Pol; 1979; 13(2):155-62. PubMed ID: 450179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Species difference of urinary excretion of delta-aminolevulinic acid and coproporphyrin in mice and rats exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y
    Toxicol Lett; 1988 Jun; 41(3):255-9. PubMed ID: 3376152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of delta-aminolevulinic acid dehydratase in venous and capillary blood and delta-aminolevulinic acid in urine of lead-exposed workers].
    Rothe R; Garlipp C
    Arch Exp Veterinarmed; 1980; 34(3):361-5. PubMed ID: 7436670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary excretion of lead and delta-aminolevulinic acid in workers occupationally exposed to tetraethyl lead.
    Duydu Y; Vural N
    Biol Trace Elem Res; 1998 Sep; 63(3):185-94. PubMed ID: 9840814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure.
    Oishi H; Nomiyama H; Nomiyama K; Tomokuni K
    J Anal Toxicol; 1996; 20(2):106-10. PubMed ID: 8868401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. δ-Aminolevulinic acid dehydratase genotype predicts toxic effects of lead on workers' peripheral nervous system.
    Zheng G; Tian L; Liang Y; Broberg K; Lei L; Guo W; Nilsson J; Bergdahl IA; Skerfving S; Jin T
    Neurotoxicology; 2011 Aug; 32(4):374-82. PubMed ID: 21439310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ALAD/EP ratio as a measure of lead toxicity.
    Beritić T; Prpić-Majić D; Karacić V; Telisman S
    J Occup Med; 1977 Aug; 19(8):551-7. PubMed ID: 894378
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical relevance of urinary delta-aminolevulinic acid/logarithm of creatinine ratio in screening for occupational lead exposure.
    Hudák A; Náray M; Süveges E
    Am J Ind Med; 1992; 21(5):673-80. PubMed ID: 1609813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time-dependent changes in lead and delta-aminolevulinic acid after subchronic lead exposure in rats.
    Kang HG; Jeong SH; Cho MR; Cho JH; Bischoff K
    Hum Exp Toxicol; 2009 Oct; 28(10):647-54. PubMed ID: 19755440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationships between blood lead concentration and aminolevulinic acid dehydratase in alcoholics and workers industrially exposed to lead.
    Bortoli A; Fazzin G; Marin V; Trabuio G; Zotti S
    Arch Environ Health; 1986; 41(4):251-60. PubMed ID: 3767434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Environmental lead exposure and activity of delta-aminolevulinic acid dehydratase (ALA-D) in maternal and cord blood.
    Campagna D; Huel G; Girard F; Sahuquillo J; Blot P
    Toxicology; 1999 Jun; 134(2-3):143-52. PubMed ID: 10403633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.